Wei-Chien Huang Selected Research

hamamelitannin

3/2021

Drug Screening of Potential Multiple Target Inhibitors for Estrogen Receptor-α-positive Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wei-Chien Huang Research Topics

Disease

42	Neoplasms (Cancer) 02/2022 - 10/2004
17	Breast Neoplasms (Breast Cancer) 10/2021 - 08/2007
12	Hepatocellular Carcinoma (Hepatoma) 02/2019 - 01/2012
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2011
8	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2013
7	Lung Neoplasms (Lung Cancer) 02/2019 - 01/2011
6	Triple Negative Breast Neoplasms 01/2021 - 01/2013
6	Carcinogenesis 01/2014 - 09/2004
5	Infections 05/2022 - 01/2012
5	Inflammation (Inflammations) 01/2022 - 09/2004
4	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 09/2013
3	COVID-19 01/2022 - 01/2021
3	Oncogene Addiction 01/2018 - 11/2013
2	Rheumatoid Arthritis 01/2022 - 01/2022
2	Experimental Arthritis 01/2022 - 01/2022
2	Chronic Hepatitis B 01/2014 - 01/2012
1	Lactic Acidosis 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Osteoarthritis 01/2022
1	Severe Acute Respiratory Syndrome 01/2021
1	Coronavirus Infections 01/2021
1	Heart Arrest (Cardiac Arrest) 01/2021
1	Anaphylaxis (Anaphylactic Shock) 01/2021
1	Bone Resorption 01/2021
1	Shock 01/2021
1	Cerebral Hemorrhage 01/2021
1	Wounds and Injuries (Trauma) 10/2019

Drug/Important Bio-Agent (IBA)

14	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2011
14	ErbB Receptors (EGF Receptor)IBA 01/2022 - 05/2008
12	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2009
10	Lapatinib (GW572016)FDA Link 10/2021 - 04/2013
6	Pharmaceutical PreparationsIBA 05/2022 - 01/2013
6	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 05/2008
6	Phosphotransferases (Kinase)IBA 01/2021 - 05/2008
6	NF-kappa B (NF-kB)IBA 11/2013 - 10/2004
4	human ERBB2 proteinIBA 10/2021 - 04/2013
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 06/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 08/2007
3	Small Interfering RNA (siRNA)IBA 02/2019 - 01/2014
3	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2019 - 03/2011
3	SmokeIBA 01/2018 - 11/2017
3	hepatitis B virus X proteinIBA 01/2016 - 01/2012
3	Gefitinib (Iressa)FDA Link 09/2013 - 01/2011
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2011 - 05/2008
2	Peptides (Polypeptides)IBA 02/2022 - 01/2013
2	CytokinesIBA 01/2022 - 01/2022
2	antcin KIBA 01/2022 - 01/2022
2	Estrogen ReceptorsIBA 03/2021 - 11/2013
2	MelatoninIBA 01/2021 - 02/2019
2	Proteasome InhibitorsIBA 09/2019 - 11/2013
2	Biological ProductsIBA 01/2019 - 05/2013
2	Conditioned Culture MediaIBA 01/2019 - 01/2018
2	Sodium-Glucose Transporter 1IBA 01/2019 - 05/2008
2	Interleukin-6 (Interleukin 6)IBA 09/2016 - 11/2015
2	SERPIN-B5 (maspin)IBA 08/2016 - 09/2015
2	MicroRNAs (MicroRNA)IBA 09/2015 - 05/2013
2	Polysaccharides (Glycans)IBA 01/2014 - 01/2012
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2014 - 09/2013
2	Messenger RNA (mRNA)IBA 01/2014 - 01/2014
2	Tyrosine (L-Tyrosine)FDA Link 09/2013 - 01/2013
2	SodiumIBA 09/2013 - 01/2013
2	SymportersIBA 09/2013 - 01/2013
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 10/2004 - 09/2004
1	GC376IBA 05/2022
1	Protein Kinase CIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Fast GreenIBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	SARS-CoV-2 spike proteinIBA 01/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	safranine T (safranin)IBA 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 09/2021
1	HesperidinIBA 08/2021
1	Pemetrexed (MTA)FDA Link 03/2021
1	hamamelitanninIBA 03/2021
1	AminopterinIBA 03/2021
1	flupirtineIBA 01/2021
1	nafamostatIBA 01/2021
1	Potassium Channels (Potassium Channel)IBA 01/2021
1	Serine Proteases (Serine Protease)IBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	capsanthinIBA 01/2021
1	p38 Mitogen-Activated Protein KinasesIBA 01/2021
1	camostatIBA 01/2021
1	Transforming Growth Factor beta (TGF-beta)IBA 10/2019
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 09/2019
1	benzyloxycarbonyl- isoleucyl- glutamyl(O- tert- butyl)- alanyl- leucinalIBA 09/2019
1	Bortezomib (Velcade)FDA Link 09/2019
1	CateninsIBA 02/2019
1	Neutralizing AntibodiesIBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	ThrombospondinsIBA 01/2019
1	Serine (L-Serine)FDA Link 01/2018
1	Carrier Proteins (Binding Protein)IBA 01/2018
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 01/2018

Therapy/Procedure

10	Therapeutics 03/2021 - 05/2008
1	Neoadjuvant Therapy 09/2021
1	Subcutaneous Injections 01/2018